Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp
Start free

AstraZeneca PLC (AZN) Profit Margins

Over the twelve months to 2026-06-30, AstraZeneca PLC (AZN) had gross margin 81.9%, operating margin 22.8%, net margin 17.0%, free cash flow margin 19.2%, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

AZNAstraZeneca PLCFollow AZN — free
Drug Manufacturers - General · Healthcare
—
Price chart with a free account
Market cap
274.1B
P/E TTM
25.7
Dividend yield
—
52-week
—
Next earnings
30 Oct, in 5 days
LineFY2017
Dec 17
FY2018
Dec 18
FY2019
Dec 19
FY2020
Dec 20
FY2021
Dec 21
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Gross margin——————82.0%81.1%81.9%81.9%
Operating margin16.4%15.3%12.0%19.4%2.8%8.5%17.9%18.5%23.4%22.8%
Net margin12.8%9.3%5.0%11.8%0.3%7.4%13.0%13.0%17.4%17.0%
FCF margin10.0%7.1%8.2%14.4%13.0%19.7%19.6%18.4%20.0%19.2%

USD billions · SEC XBRL

AstraZeneca PLC — questions

What is AstraZeneca PLC's gross margin?
81.9% over the twelve months to 2026-06-30.
What is AstraZeneca PLC's operating margin?
22.8% over the twelve months to 2026-06-30.
What is AstraZeneca PLC's net profit margin?
17.0% over the twelve months to 2026-06-30.

Every figure on this page comes from AstraZeneca PLC's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.